Adherence to Long-Term Therapies - Evidence for Action
(2003; 211 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentAcknowledgements
View the documentScientific writers
View the documentIntroduction
View the documentTake-home messages
Open this folder and view contentsSection I - Setting the scene
Open this folder and view contentsSection II - Improving adherence rates: guidance for countries
Close this folderSection III - Disease-Specific Reviews
Open this folder and view contentsChapter VII - Asthma
Close this folderChapter VIII - Cancer (Palliative care)
View the document1. Definitions and epidemiology of adherence
View the document2. Factors and interventions affecting adherence
View the document3. Conclusions
View the document4. References
Open this folder and view contentsChapter IX - Depression
Open this folder and view contentsChapter X - Diabetes
Open this folder and view contentsChapter XI - Epilepsy
Open this folder and view contentsChapter XII - Human immunodeficiency virus and acquired immunodeficiency syndrome
Open this folder and view contentsChapter XIII - Hypertension
Open this folder and view contentsChapter XIV - Tobacco smoking cessation
Open this folder and view contentsChapter XV - Tuberculosis
Open this folder and view contentsAnnexes
Open this folder and view contentsWhere to find a copy of this book
 

3. Conclusions

Definitions and measurements of adherence vary widely; this prevents comparisons being made between studies and populations. There is little information on the adherence to palliative treatment of patients with cancer, and it covers only treatments for relief of pain. The available information reports adherence rates ranging from 24.7% to 88.9%. A general programme of palliative care must include the management of adherence in order to improve the effectiveness of the interventions and ensure an acceptable quality of life for this group of patients.

More research on adherence to palliative care is required in the following areas:

- epidemiology of adherence, especially to medicines other than those for pain relief;

- determination of the most appropriate methods and definitions for the measurement of adherence to analgesic medications;

- determining the additional factors that contribute to a patient's level of adherence to all required therapies; and

- studies evaluating interventions to improve adherence to all required therapies.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014